Alignment Healthcare has slipped into an $8 million net loss, underscoring the persistent industrywide challenges involving the escalating costs of providing medical care to older adults enrolled in Medicare Advantage plans.

Similar to numerous competitor health insurers operating within the Medicare Advantage sector, Alignment has faced mounting medical expenditures stemming from plan participants requiring healthcare services.

Third-Quarter Financial Pressures

The third-quarter earnings report released on Thursday highlighted persistently high expenditures, pushing the company’s medical benefit ratio—the proportion of premium revenue allocated directly to medical care—to nearly 90%. These mounting cost pressures directly influenced leadership's strategy to lower profit projections for the remainder of the year.

Medical benefits ratio based on adjusted gross profit was 89.5%, an increase of approximately 240 basis points year-over-year, Alignment stated in its official earnings disclosure.

The company attributed the elevated medical benefits ratio to anticipated shifts in Part D seasonality and the timing of clinical investments. Additional drivers included increased expenses from heightened appeals and disputes, alongside rising costs within catastrophic cases and skilled nursing categories.

Broader Industry Trends in Medicare Advantage

Across the insurance landscape, medical loss ratios have climbed to 90% and higher. This surge follows a wave of claims submitted by hospitals and physicians dealing with a surge of patients exhibiting pent-up demand for medical interventions, particularly within Medicare Advantage portfolios. Ideally, health insurance providers target ratios sitting below 90% and reaching into the mid-80s, levels that were commonplace less than two years ago.

Medicare Advantage programs operate through contracts with the federal government, delivering standard traditional Medicare benefits supplemented by additional services for seniors. These offerings frequently encompass disease management, prescription drug coverage, and nurse assistance hotlines, with select plans extending dental, vision, and wellness initiatives.

Revenue Growth and Future Outlook

Despite logging a net loss of $8.05 million, or 4 cents per share—a stark contrast to the net income of $3.7 million, or 2 cents a share, recorded during the corresponding period last year—Alignment achieved substantial top-line gains. Third-quarter revenue surged by roughly 37% to $1.36 billion, largely propelled by a 31% expansion in health plan membership, which reached 301,200 enrollees.

Company leadership expressed optimism regarding a turnaround, emphasizing sustained momentum in both revenue generation and customer acquisition.

Our third-quarter membership and revenue growth demonstrate continued demand for Alignment’s products and services, while medical trends ran higher than expected, said John Kao, chairman and chief executive officer at Alignment.

Kao added that the enterprise is adopting a cautious stance heading into the fourth quarter, adjusting guidance downward in response to prevailing headwinds. While the revised projections exclude any potential upside from ongoing corrective measures, executive management remains assured in its ability to meet these targets. The primary objective centers on flawless execution and implementing strategic adjustments to secure steady performance, scale operations, and generate profitable long-term growth.